Tags

Type your tag names separated by a space and hit enter

Baseline Interleukin-6 and Erythrocyte Sedimentation Rate Can Predict Clinical Response of TNF Inhibitor Treatment in Patients with Ankylosing Spondylitis.
Ann Clin Lab Sci 2019; 49(5):611-618AC

Abstract

OBJECTIVE

The objective of this study is to investigate the baseline predictors of clinical response from tumor necrosis factor (TNF) inhibitor within ankylosing spondylitis (AS) patients.

METHODS

We selected 60 AS patients and 24 healthy individuals. The interleukin (IL)-1β, IL-6, IL-17A and TNF-α levels were measured using the cytometric bead array. The receiver operating characteristic curve was used to analyze the cut off values of baseline predictors. A binary logistic regression test was used to investigate the association between baseline predictors and clinical response.

RESULTS

At baseline, the IL-1β, IL-6 and TNF-α level were positively correlated with disease activity. After 12 weeks of treatment, good responders had lower baseline IL-6 level and erythrocyte sedimentation rate (ESR) than non/poor responders. The cut off value of baseline IL-6 level and ESR to predict clinical response of TNF inhibitor treatment were 9.05 pg/mL and 47.00 mm/h, respectively. Binary logistic regression found that baseline IL-6 levels and ESR had an adverse relationship with clinical response, and the combination of IL-6 level and ESR could predict clinical response more effectively.

CONCLUSIONS

The baseline IL-6 level and ESR can predict the clinical response of TNF inhibitor treatment within AS patients, which might facilitate the selection and adjustment of medication regimens for subjects.

Authors+Show Affiliations

Department of Rheumatology and Immunology of China-Japan Union Hospital of Jilin University, Changchun, China.Department of Rheumatology and Immunology of China-Japan Union Hospital of Jilin University, Changchun, China.Department of Rheumatology and Immunology of China-Japan Union Hospital of Jilin University, Changchun, China biliqi66@126.com.

Pub Type(s)

Journal Article

Language

eng

PubMed ID

31611204

Citation

Dong, Yidian, et al. "Baseline Interleukin-6 and Erythrocyte Sedimentation Rate Can Predict Clinical Response of TNF Inhibitor Treatment in Patients With Ankylosing Spondylitis." Annals of Clinical and Laboratory Science, vol. 49, no. 5, 2019, pp. 611-618.
Dong Y, Guo J, Bi L. Baseline Interleukin-6 and Erythrocyte Sedimentation Rate Can Predict Clinical Response of TNF Inhibitor Treatment in Patients with Ankylosing Spondylitis. Ann Clin Lab Sci. 2019;49(5):611-618.
Dong, Y., Guo, J., & Bi, L. (2019). Baseline Interleukin-6 and Erythrocyte Sedimentation Rate Can Predict Clinical Response of TNF Inhibitor Treatment in Patients with Ankylosing Spondylitis. Annals of Clinical and Laboratory Science, 49(5), pp. 611-618.
Dong Y, Guo J, Bi L. Baseline Interleukin-6 and Erythrocyte Sedimentation Rate Can Predict Clinical Response of TNF Inhibitor Treatment in Patients With Ankylosing Spondylitis. Ann Clin Lab Sci. 2019;49(5):611-618. PubMed PMID: 31611204.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - Baseline Interleukin-6 and Erythrocyte Sedimentation Rate Can Predict Clinical Response of TNF Inhibitor Treatment in Patients with Ankylosing Spondylitis. AU - Dong,Yidian, AU - Guo,Jialong, AU - Bi,Liqi, PY - 2019/10/16/entrez KW - IL-6 KW - ankylosing spondylitis KW - biosimilar KW - erythrocyte sedimentation rate KW - etanercept SP - 611 EP - 618 JF - Annals of clinical and laboratory science JO - Ann. Clin. Lab. Sci. VL - 49 IS - 5 N2 - OBJECTIVE: The objective of this study is to investigate the baseline predictors of clinical response from tumor necrosis factor (TNF) inhibitor within ankylosing spondylitis (AS) patients. METHODS: We selected 60 AS patients and 24 healthy individuals. The interleukin (IL)-1β, IL-6, IL-17A and TNF-α levels were measured using the cytometric bead array. The receiver operating characteristic curve was used to analyze the cut off values of baseline predictors. A binary logistic regression test was used to investigate the association between baseline predictors and clinical response. RESULTS: At baseline, the IL-1β, IL-6 and TNF-α level were positively correlated with disease activity. After 12 weeks of treatment, good responders had lower baseline IL-6 level and erythrocyte sedimentation rate (ESR) than non/poor responders. The cut off value of baseline IL-6 level and ESR to predict clinical response of TNF inhibitor treatment were 9.05 pg/mL and 47.00 mm/h, respectively. Binary logistic regression found that baseline IL-6 levels and ESR had an adverse relationship with clinical response, and the combination of IL-6 level and ESR could predict clinical response more effectively. CONCLUSIONS: The baseline IL-6 level and ESR can predict the clinical response of TNF inhibitor treatment within AS patients, which might facilitate the selection and adjustment of medication regimens for subjects. SN - 1550-8080 UR - https://www.unboundmedicine.com/medline/citation/31611204/Baseline_Interleukin-6_and_Erythrocyte_Sedimentation_Rate_Can_Predict_Clinical_Response_of_TNF_Inhibitor_Treatment_in_Patients_with_Ankylosing_Spondylitis L2 - http://www.annclinlabsci.org/cgi/pmidlookup?view=long&pmid=31611204 DB - PRIME DP - Unbound Medicine ER -